Introduction

Materials and methods
Alkylating agents exert profound cytotoxic effects on actively
Gene-targeted mice growing cells and this is the basic rationale for the use of Development of Mgmt gene-disrupted mice was as described (8) . Genotypes these agents in cancer chemotherapy (1, 2) . The biological of mice were identified by PCR (15). The resulting PCR products were effects of alkylating agents are attributed to the formation of resolved by electrophoresis on 1.5% agarose gels and visualized under UV alkylated bases in cellular DNA. Among various modified light after staining with ethidium bromide. bases produced in DNA by alkylating agents, O 6 
-alkylguanine
Sensitivity to drugs
is critical for inducing cell death, as well as mutation (3) (4) (5) .
Dacarbazine was purchased from Kyowa Co. (Tokyo, Japan). ACNU and This was clearly shown in recent studies with cell lines in cyclophosphamide were obtained from Sankyo Co. (Tokyo, Japan) and which both alleles of the gene for O 6 -methylguanine-DNA Shionogi Co. (Osaka, Japan), respectively. These drugs were dissolved in methyltransferase were disrupted by gene targeting (6) . The 0.9% NaCl. Six-week-old mice were given an i.p. injection of 200 µl of the enzyme specifically repairs O 6 -methylguanine and O 4 -methyldrug solution at defined concentrations. As controls, mice were given an i.p. injection of 200 µl of 0.9% NaCl. Mice were kept for defined periods and thymine, the latter being produced less frequently as compared survivors were scored.
Peripheral blood analysis
Abbreviations: ACNU, 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-Counts of total peripheral blood platelets were made on tail vein blood, using chloroethyl)-3-nitrosourea; MNU, N-methyl-N-nitrosourea; MTD, maximum tolerated dose.
an automatic hematopoietic cell counter.
Fig. 2.
Changes in number of platelets after dacarbazine administration. Two groups of mice were given dacarbazine (4 mg/kg body wt each time) on five consecutive days at post-natal week 6 and other groups of mice (controls) were given 200 µl of 0.9% NaCl at the same times. Arrows indicate the times of drug application. Data are the means of measurements between two and four mice for each point. s, saline-administered Mgmt -/-mice; d, dacarbazine-administered Mgmt -/-mice; u, saline-administered Mgmt ϩ/ϩ mice; j, dacarbazine-administered Mgmt ϩ/ϩ mice. 
Tumor induction
Mice were given i.p. injections of 4 mg/kg body wt dacarbazine daily for five consecutive days at post-natal week 6. Twenty-four weeks after injection, these mice were killed and tissues were examined as described earlier (10) .
Results
Susceptibility of Mgmt gene knockout mice to dacarbazine
As a representative of chemotherapeutic alkylating agents, we selected dacarbazine, which is presently in use for treatment of malignant melanoma (13,16). Susceptibility of mice to dacarbazine was examined by applying a fixed dose of the drug to Mgmt ϩ/ϩ and Mgmt -/-mice. Two types of mice, each consisting of 10 animals (6 weeks old), were given a single i.p. injection of dacarbazine (100 mg/kg body wt). As shown in Figure 1 , there was a distinct difference in survival of the days after treatment). As controls, 0.9% NaCl was injected into the two types of mice and all survived for Ͼ3 months (data not shown).
for Ͼ1 week. The change in the number of platelets was nil After dacarbazine treatment, internal organs of Mgmt -/-in Mgmt ϩ/ϩ mice treated in a similar manner, as was the case mice, especially those related to rapid reproduction of cells, for both types of mice receiving 0.9% NaCl. Methyltransferase such as bone marrow, were severely damaged. In addition to apparently protects the reproductive capacity of hematopoietic anemia and bleeding, diarrhea and alopecia were remarkable stem cells from alkylation damage. in Mgmt -/-mice treated with dacarbazine. These effects of Tumor formation by dacarbazine dacarbazine are similar to those which we observed with Mgmt -/-mice treated with MNU (8) .
To determine sub-lethal doses of dacarbazine for tumorigenesis experiments, various doses of the drug were given to groups When Mgmt -/-mice were given a sub-lethal dose of dacarbazine, myelosuppression was evident. Figure 2 shows changes of mice with Mgmt ϩ/ϩ , Mgmt ϩ/-and Mgmt -/-backgrounds. Figure 3 shows survival curves for the three types of mice, in number of platelets in peripheral blood after application of 4 mg/kg body wt of the drug for five consecutive days. A determined on day 30 of treatment. From the curves, the LD 50 in Mgmt -/-mice was estimated to be 20 mg/kg body wt while dramatic decrease in the number of platelets was observed at an early stage of treatment and this thrombocytopenia continued the values for Mgmt ϩ/ϩ and Mgmt ϩ/-mice were as high as 450 mg/kg. It seems that a single copy of the Mgmt gene is sufficient to provide full repair potency for these mice. Six-week-old mice with the Mgmt ϩ/ϩ and Mgmt -/-genotypes (~50 each) were given a single i.p. injection of dacarbazine (4 mg/kg body wt) for five consecutive days. The animals were killed 24 weeks after drug administration and their organs examined. As shown in Table I , thymic lymphomas were found in two of 52 Mgmt -/-mice, one of which died within 18 weeks after dacarbazine administration. The tumor was 0.18 g, six times heavier than the normal thymus. No lymphoma was found in Mgmt ϩ/ϩ mice treated in the same manner. The histology of tumors induced by dacarbazine was similar to that of tumors produced by MNU (10) .
Lung adenomas were frequent in dacarbazine-treated Mgmt -/-mice, while there were only a few in Mgmt ϩ/ϩ animals. Since one lung adenoma was found in a control Mgmt ϩ/ϩ mouse not given dacarbazine administration, tumor incidence observed in the treated Mgmt ϩ/ϩ mice may be regarded as background. It seems that mice defective in both alleles of the Mgmt gene are more vulnerable to dacarbazineinduced tumorigenesis than are wild-type mice.
The size of testes of male Mgmt -/-mice was considerably reduced after dacarbazine treatment. The mean weight of testes in dacarbazine-treated Mgmt -/-mice was 32.8 mg, whereas the value for mock-treated Mgmt -/-mice was 125.8 mg. There were no differences in Mgmt ϩ/ϩ mice treated with dacarbazine and untreated Mgmt ϩ/ϩ mice (128.5 and 114.9 mg, respectively).
Effects of other types of drugs with alkylation potential
In addition to dacarbazine, there are several drugs in clinical use the activities of which are related to the capacity for alkylation of DNA. For our study we used ACNU (2) and cyclophosphamide (12) , which belong to the bifunctional nitrosourea and nitrogen mustard groups of drugs, respectively. Figure 4 shows survival of methyltransferase-proficient and -deficient mice after treatment with these drugs. ACNU wt, respectively ( Figure 4A ). This difference in survival ratio between the LD 50 values for dacarbazine in Mgmt ϩ/ϩ and Mgmt -/-mice is even higher than the ratio for MNU. Thus, dacarbazine is as effective as MNU with regard to cell killing.
In the present tumorigenesis experiments with dacarbazine and previous studies with MNU (10) , the age of the mice given the two agents and the observation periods differed slightly. As to the dose, 2.5 mg/kg body wt MNU is half the maximum tolerated dose (MTD) and 20 mg/kg body wt (4 mg each five times) dacarbazine is twice the MTD. At postnatal week 30 Mgmt -/-mice administered MNU had thymic lymphomas and lung adenomas more frequently than did Mgmt -/-mice administered dacarbazine. Dacarbazine administration apparently led to fewer tumors as compared with MNU.
Carcinogenicity of dacarbazine has been tested by giving test period there were large numbers of lung tumors and lymphomas in these treated mice. In our experiment, cumulatbetween Mgmt ϩ/ϩ and Mgmt -/-mice with regard to ACNU is ive exposure of Mgmt -/-mice was 20 mg/kg body wt (estimated less dramatic than that observed with dacarbazine, but is as~110 mg/m 2 body surface), about one hundredth of the significant.
dose used in former carcinogenicity tests. These low levels of No significant difference was observed in susceptibility of dacarbazine are almost equal to or less than the doses given the two types of mice to cyclophosphamide ( Figure 4B ).
clinically (21) . Mgmt -/-mice exhibited severe myelosuppresMgmt -/-mice exhibited the same level of resistance as did sion and formation of secondary tumors under conditions much Mgmt ϩ/ϩ mice. the same as those used for chemotherapy. These profound effects of dacarbazine in Mgmt -/-mice raise the question as Discussion to whether application of this type of drug may be hazardous for patients, especially those with the Mgmt -/-trait. It is To treat subjects with malignant tumors, various chemicals expected that in human populations there are various levels of with alkylation capacity have been developed and some are methyltransferase activity (22, 23) . Therefore, we consider it presently in clinical use. We selected three drugs, dacarbazine, ACNU and cyclophosphamide, which are representatives of important to examine levels of methyltransferase activity prior monofunctional triazenes, bifunctional chloroethylnitrosoureas to application of these drugs to patients. There is the possibility and nitrogen mustards, respectively (2,12,13). Figure 5 shows that patients lacking methyltransferase activity might suffer the structures of these drugs, together with that of MNU, a severe myelosuppression and further be at increased risk for simple alkylating agent. These three drugs have the potential secondary tumors. to alkylate various functional groups of proteins, nucleic acids Similar but less striking effects on methyltransferase-defiand other cellular constituents after metabolic activation. cient mice were observed with chloroethylnitrosoureas (2,24). Although many groups of various substances in organisms
We have shown, in the present study, that the LD 50 values for could be modified by these drugs, the most important of these ACNU in Mgmt ϩ/ϩ and Mgmt -/-mice were 70 and 14 mg/kg is alkylation of the base moieties of DNA. This type of body wt, while Glassner et al. (9) reported that these values modification affects DNA metabolism and, in particular, blocks for N,N-bis(2-chloroethyl)-N-nitrosourea were 39 and 14 mg/ replication. It is expected that rapidly growing cells, including kg body wt, respectively. These drugs have been used for cells in tumor tissues, are preferentially attacked by these treatment of subjects with brain tumors, since these drugs pass agents.
the blood-brain barrier (25). On application of these drugs Among various modified bases produced in DNA by alkylatchloroethyl groups of nitrosoureas are transferred to a guanine ing agents, O 6 -methylguanine has been regarded as critical in residue of DNA and finally yield a crosslink with a base on cell killing as well as mutation induction. This was clearly the opposite strand, thereby preventing cell proliferation (26). shown by recent studies with cell lines and mice defective in
The chloroethyl group at the O 6 position of guanine in DNA O 6 -methylguanine-DNA methyltransferase (6) (7) (8) (9) . Lack of the can be recognized and repaired by O 6 -methylguanine-DNA enzyme makes mice hypersensitive to MNU with respect to methyltransferase (27,28). The finding that Mgmt -/-mice are both survival and tumor induction. Here we used these genemore sensitive to chloroethylnitrosourea alkylating agents than targeted animals to evaluate biological activities of chemotheraare wild-type mice implies that relatively large numbers of peutic agents with the potential for alkylation. unpaired chloroethyl groups are present in the DNA, becoming Our studies focused on the action of dacarbazine, a triazene the primary cause of cell death. Cyclophosphamide, on the type of antitumor drug (13). The LD 50 value of dacarbazine other hand, alkylates other moieties of DNA, yielding 7-in Mgmt -/-mice was~20 times lower than that for methyltranssubstituted guanine and other alkylated bases (12, 14) . These ferase-proficient wild-type mice. Although dacarbazine modified bases are not recognized by the methyltransferase requires metabolic activation for its action (17-19) while MNU enzyme and, indeed, there are no differences in sensitivity of acts directly on DNA, their actions in the cell can apparently be ascribed to formation of O 6 -methylguanine in DNA. The
Mgmt ϩ/ϩ and Mgmt -/-mice.
